Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | STC-15 |
| Synonyms | |
| Therapy Description |
STC-15 inhibits METTL3, potentially resulting in antitumor activity (PMID: 34228629) |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| STC-15 | STC15|STC 15 | STC-15 inhibits METTL3, potentially resulting in antitumor activity (PMID: 34228629) |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT05584111 | Phase I | STC-15 | Oral Administration of STC-15 in Subjects With Advanced Malignancies | Completed | USA | 0 |